This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Maturi B, Mikhael JR, Dunlop WCN, Tilden DT, Wong L.Maintenance therapy with rituximab for follicular lymphoma is cost-effective - a Canadian perspective. Blood 108: 106-107, No. 11, Part 1, Nov 2006
Rights and permissions
About this article
Cite this article
Rituximab maintenance therapy worth it in follicular lymphoma. Pharmacoecon. Outcomes News 521, 7 (2007). https://doi.org/10.2165/00151234-200705210-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705210-00022